TXT
42
3
BDX
65
2
DVA
66
5
JPM
56
6
AFL
37
3
DD
40
4
MTCH
55
18
PEP
33
4
IP
48
-2
ALLE
19
3
PCAR
45
3
MLM
31
2
BK
60
2
RIG
43
2
JCI
42
2
IVZ
33
3
CVX
35
4
USB
53
3
IBM
41
-3
HP
59
3
TXT
42
3
BDX
65
2
DVA
66
5
JPM
56
6
AFL
37
3
DD
40
4
MTCH
55
18
PEP
33
4
IP
48
-2
ALLE
19
3
PCAR
45
3
MLM
31
2
BK
60
2
RIG
43
2
JCI
42
2
IVZ
33
3
CVX
35
4
USB
53
3
IBM
41
-3
HP
59
3
Financhill
Back

NovoCure Stock Price Chart

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free
Sell
35

NVCR
NovoCure

Last Price:
$26.23
Seasonality Move:
-0.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free
  • The current trend is moderately bearish and NVCR is experiencing slight buying pressure.

NovoCure Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 29.05 Sell
20-day SMA: 30.33 Sell
50-day SMA: 24.44 Buy
200-day SMA: 19.26 Buy
8-day EMA: 28.8 Sell
20-day EMA: 28.88 Sell
50-day EMA: 25.77 Buy
200-day EMA: 21.57 Buy

NovoCure Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 46.03 Sell
Chaikin Money Flow: 204115 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.45 - 31.61) Sell
Bollinger Bands (100): (14.63 - 26.63) Buy

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NovoCure Stock

Is NovoCure Stock a Buy?

  • NovoCure share price is 27.38 while NVCR 8-day simple moving average is 29.05, which is a Sell signal.
  • The stock price of NVCR is 27.38 while NovoCure 20-day SMA is 30.33, which makes it a Sell.
  • NovoCure 50-day simple moving average is 24.44 while NVCR share price is 27.38, making it a Buy technically.
  • NVCR stock price is 27.38 and NovoCure 200-day simple moving average is 19.26, creating a Buy signal.

NVCR Technical Analysis vs Fundamental Analysis

Sell
35
NovoCure (NVCR) is a Sell

Is NovoCure a Buy or a Sell?

  • NovoCure stock is rated a Sell
    The current NovoCure [NVCR] share price is $27.38. The Score for NVCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.

NovoCure Stock Info

Market Cap:
3B
Price in USD:
27.38
Share Volume:
1.8M

NovoCure 52-Week Range

52-Week High:
34.13
52-Week Low:
11.70
Sell
35
NovoCure (NVCR) is a Sell

NovoCure Share Price Forecast

  • What is the NovoCure stock price today?
    The NovoCure stock price is 27.38 USD today.
  • Will NVCR stock go up or go down?
    NovoCure> share price is forecast to RISE/FALL based on technical indicators
  • Is NovoCure overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.

Is NovoCure Stock a Buy?

  • NovoCure share price is 27.38 while NVCR 8-day exponential moving average is 28.80, which is a Sell signal.
  • The stock price of NVCR is 27.38 while NovoCure 20-day EMA is 28.88, which makes it a Sell.
  • NovoCure 50-day exponential moving average is 25.77 while NVCR share price is 27.38, making it a Buy technically.
  • NVCR stock price is 27.38 and NovoCure 200-day simple moving average is 21.57, creating a Buy signal.

Fundamental Analysis of NovoCure

Is NovoCure a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

Technical Analysis of NovoCure

Should I short NovoCure stock?

  • NVCR Moving Average Covergence Divergence (MACD) indicator is 0.81, suggesting NovoCure is a Buy
  • NovoCure Relative Strength Index (RSI) is 46.03, which suggest NovoCure is oversold
  • The Bollinger Bands (25) for NovoCure is (28.45 - 31.61), which suggest NovoCure is a Buy
  • The Bollinger Bands (100) for NovoCure is (14.63 - 26.63), which suggest NovoCure is a Buy

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.